Overview of Donor Screening

The FMT donor screening process is one of the most rigorous medical screening protocols, designed to ensure patient safety and treatment efficacy. Only 2-3% of potential donors pass the complete screening process, making qualified FMT donors extremely rare.

Initial Screening Phase

Health Questionnaire

Comprehensive medical history assessment covering:

  • Past and current medical conditions
  • Medication usage (especially antibiotics)
  • Travel history to endemic areas
  • Family medical history
  • Lifestyle factors and diet

Physical Examination

Thorough clinical assessment including:

  • General health evaluation
  • BMI and weight assessment
  • Vital signs monitoring
  • Gastrointestinal health review

Laboratory Testing

Extensive laboratory workup is performed to screen for infectious diseases and assess overall health:

Blood Tests

  • Complete blood count (CBC)
  • Comprehensive metabolic panel
  • Liver function tests
  • Hepatitis A, B, C
  • HIV 1 & 2
  • Syphilis (RPR)
  • HTLV-1

Stool Testing

  • Bacterial pathogens (Salmonella, Shigella, Campylobacter)
  • Parasites (Ova and parasites exam)
  • Giardia and Cryptosporidium antigens
  • C. difficile toxin
  • Norovirus and rotavirus
  • Helicobacter pylori
  • Vancomycin-resistant Enterococcus (VRE)
  • Extended-spectrum beta-lactamase (ESBL) producing bacteria

Advanced Screening

Microbiome Analysis

Comprehensive analysis of the donor's gut microbiome including:

  • Microbial diversity assessment
  • Beneficial bacteria abundance
  • Absence of pathogenic organisms
  • Metabolic activity evaluation

Genetic Testing

Screening for genetic markers that may affect transplant success:

  • Antibiotic resistance genes
  • Virulence factors
  • Metabolic pathway genes

Exclusion Criteria

Potential donors are excluded if they have:

Medical History

  • Antibiotic use within 3-6 months
  • Gastrointestinal disorders
  • Autoimmune conditions
  • Metabolic disorders
  • Mental health conditions requiring medication
  • History of malignancy

Risk Factors

  • High-risk sexual behavior
  • Intravenous drug use
  • Recent travel to endemic areas
  • Tattoos or piercings within 6 months
  • Recent vaccinations
  • Close contact with infectious individuals

Quality Control & Storage

Once a donor is approved:

  • Fresh sampling: Stool collected within 6 hours of donation
  • Processing: Immediate processing under sterile conditions
  • Testing: Each donation individually tested
  • Storage: Frozen at -80°C to preserve viability
  • Tracking: Complete chain of custody documentation

Ongoing Monitoring

Approved donors undergo regular re-screening:

  • Monthly health questionnaires
  • Quarterly blood and stool testing
  • Annual comprehensive screening
  • Immediate reporting of any health changes

Disclaimer: This information is for educational purposes only and is not intended as medical advice. FMT should only be performed at qualified medical facilities with properly screened donors. Consult with healthcare professionals for treatment decisions.